SCHEMBL4853565

SCHEMBL4853565

O=C(F)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.70
GAA P10253 1/20 0.48
RXRA P19793 1/20 0.48
RXRB P28702 1/20 0.48
RXRG P48443 1/20 0.48
P2RX1 P51575 2/20 0.46
CES1 P23141 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
NOTUM Q6P988 1/20 0.44
MAPT P10636 1/20 0.44
TACR1 P25103 1/20 0.42
HIF1A Q16665 1/20 0.41
GPR35 Q9HC97 1/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
LMNA P02545 1/20 0.40
SRD5A2 P31213 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16180051 0.82 CES2 (0.73) CES2GAARXRARXRBRXRG
SCHEMBL11131496 0.80 CES2 (0.47) CES2GAARXRARXRBRXRG
SCHEMBL22981333 0.80 CES2 (0.70) CES2GAARXRARXRBRXRG
SCHEMBL503980 0.80 CES2 (0.70) CES2GAARXRARXRBRXRG
SCHEMBL2191271 0.80 CES2 (0.70) CES2GAARXRARXRBRXRG
SCHEMBL5778879 0.79 CES2 (0.61) CES2GAARXRARXRBRXRG
SCHEMBL2090686 0.78 CES2 (0.67) CES2GAARXRARXRBRXRG
SCHEMBL96116 0.78 CES2 (0.67) CES2GAARXRARXRBRXRG
Hydrochloric Acid SCHEMBL7485970 0.78 CES2 (0.67) CES2GAARXRARXRBRXRG
SCHEMBL3550111 0.78 CES2 (0.67) CES2GAARXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125913-B1 Preparation of 3,5-bis-(trifluormethyl)-benzoylchlorid and novel benzoylhalides: 3,5-bis-(trihalomethyl)- and 3,5-dimethyl- BAYER AG (DE) 2003-04-09 EP claimed
EP-1125913-A1 Preparation of 3,5-bis-(trifluormethyl)-benzoylchlorid and novel benzoylhalides: 3,5-bis-(trihalomethyl)- and 3,5-dimethyl- BAYER AG (DE) 2001-08-22 EP claimed
US-7405331-B2 High-purity (fluoroalkyl)benzene derivative and process for producing the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2008-07-29 US disclosed
US-20060167324-A1 High-purity (fluoroalkyl)benzene derivative and process for producing the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-07-27 US disclosed
EP-1500641-A1 HIGH-PURITY (FLUOROALKYL)BENZENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2005-01-26 EP disclosed
EP-1125913-B1 Preparation of 3,5-bis-(trifluormethyl)-benzoylchlorid and novel benzoylhalides: 3,5-bis-(trihalomethyl)- and 3,5-dimethyl- BAYER AG (DE) 2003-04-09 EP disclosed
US-6420601-B2 FREE RADICAL CHLORINATION; FLUORINATION WITH HYDROGEN FLUORIDE AND/OR ANTIMONY PENTAFLUORIDE; CONVERTING THE BENZOYL FLUORIDE TO CHLORIDE BY REACTING WITH SILICON TETRACHLORIDE IN LEWIS ACID; CHEMICAL INTERMEDIATES BAYER AKTIENGESELLSCHAFT (DE) 2002-07-16 US disclosed
JP-2001294551-A METHOD FOR PRODUCING 3,5-BIS(TRIFLUOROMETHYL)BENZOYL CHLORIDE AND NEW 3,5-BIS(TRIHALOGENOMETHYL)- AND 3,5- DIMETHYLBENZOYL HALIDES BAYER AG 2001-10-23 JP disclosed
EP-1125913-A1 Preparation of 3,5-bis-(trifluormethyl)-benzoylchlorid and novel benzoylhalides: 3,5-bis-(trihalomethyl)- and 3,5-dimethyl- BAYER AG (DE) 2001-08-22 EP disclosed
EP-1125913-A1 Preparation of 3,5-bis-(trifluormethyl)-benzoylchlorid and novel benzoylhalides: 3,5-bis-(trihalomethyl)- and 3,5-dimethyl- BAYER AG (DE) 2001-08-22 EP disclosed
US-20010014759-A1 Free radical chlorination; fluorination with hydrogen fluoride and/or antimony pentafluoride; converting the benzoyl fluoride to chloride by reacting with silicon tetrachloride in lewis acid; chemical intermediates LANXESS DEUTSCHLAND GMBH (DE) 2001-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010014759-A1 Free radical chlorination; fluorination with hydrogen fluoride and/or antimony pentafluoride; converting the benzoyl fluoride to chloride by reacting with silicon tetrachloride in lewis acid; chemical intermediates SCLY, SSB, CLIC4 CES2 836/4885GAA 2525/4885RXRA 1091/4885
US-20060167324-A1 High-purity (fluoroalkyl)benzene derivative and process for producing the same HBB, AFF4, AFF2 CES2 2075/4885GAA 937/4885RXRA 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.